Transgene Market Cap

Transgene has a market cap or net worth of 76.49 million as of January 31, 2025. Its market cap has decreased by -31.89% in one year.

Market Cap

76.49M

Enterprise Value

94.43M

Revenue

5.51M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.69

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 98.01M to 76.49M, a decrease of -21.96%. That is a compound annual growth rate of -0.92%.

Market Cap History

Date	Market Cap	% Change
Jan 31, 2025	76.49M	3.05%
Dec 31, 2024	74.22M	-37.92%
Dec 29, 2023	119.56M	-18.19%
Dec 30, 2022	146.14M	-29.80%
Dec 31, 2021	208.16M	68.48%
Dec 31, 2020	123.55M	13.08%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	175.89B
GSK plc	57.33B
Haleon	33.92B
Smith & Nephew	9.00B
Hikma Pharmaceuticals	5.08B
ConvaTec Group	5.06B
HUTCHMED (China)	1.88B
Oxford Nanopore Technologies	1.39B

Market Cap Rankings